Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Thomas Bak

Concepts (121)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Transplantation
22
2022
695
1.040
Why?
Living Donors
8
2022
270
0.370
Why?
Hepatic Artery
3
2004
49
0.310
Why?
Carcinoma, Hepatocellular
5
2007
210
0.270
Why?
Intestinal Fistula
1
2004
11
0.240
Why?
Duodenal Diseases
1
2004
8
0.240
Why?
Vascular Fistula
1
2004
14
0.240
Why?
Liver Neoplasms
5
2007
504
0.230
Why?
Aneurysm, False
1
2004
45
0.230
Why?
Immunosuppressive Agents
8
2008
641
0.220
Why?
Cholangitis, Sclerosing
4
2008
66
0.170
Why?
Sirolimus
3
2007
181
0.130
Why?
Liver Failure
2
2008
73
0.130
Why?
Donor Selection
1
2016
65
0.120
Why?
Airway Extubation
1
2016
43
0.120
Why?
Oxygen Inhalation Therapy
1
2016
127
0.120
Why?
Tissue Donors
1
2016
314
0.110
Why?
Cholestasis
1
2016
225
0.110
Why?
Graft Rejection
3
2007
511
0.100
Why?
Tacrolimus
3
2007
134
0.090
Why?
Hypoxia
1
2016
956
0.080
Why?
Graft Survival
5
2016
443
0.080
Why?
Hepatitis, Autoimmune
1
2008
27
0.080
Why?
Hepatic Veins
1
2008
29
0.070
Why?
Chemoembolization, Therapeutic
2
2007
45
0.070
Why?
Cadaver
3
2004
298
0.070
Why?
Hepatectomy
1
2008
118
0.070
Why?
Portasystemic Shunt, Transjugular Intrahepatic
1
2006
36
0.070
Why?
Tissue and Organ Procurement
3
2004
226
0.060
Why?
Portal Vein
1
2006
75
0.060
Why?
Disease Transmission, Infectious
1
2006
54
0.060
Why?
Bile Ducts
2
2022
68
0.060
Why?
Anastomosis, Roux-en-Y
2
2022
25
0.060
Why?
Herpes Simplex
1
2006
87
0.060
Why?
Middle Aged
15
2016
26607
0.060
Why?
Adrenal Cortex Hormones
1
2008
493
0.060
Why?
Venous Thrombosis
1
2006
141
0.060
Why?
Reoperation
3
2016
513
0.050
Why?
Vena Cava, Inferior
1
2004
56
0.050
Why?
Survival Analysis
4
2008
1206
0.050
Why?
Choledochostomy
1
2022
11
0.050
Why?
Treatment Outcome
7
2016
9049
0.050
Why?
Adult
11
2016
30377
0.050
Why?
Hepatocytes
1
2003
195
0.050
Why?
Hospital Costs
1
2003
104
0.050
Why?
Humans
23
2022
114049
0.050
Why?
Female
16
2016
59326
0.050
Why?
Vascular Surgical Procedures
1
2004
260
0.050
Why?
Hepatitis C
1
2003
218
0.050
Why?
Retrospective Studies
8
2016
12521
0.040
Why?
Pancreas Transplantation
1
2000
61
0.040
Why?
Male
16
2016
55398
0.040
Why?
Recurrence
3
2008
925
0.040
Why?
Glucocorticoids
1
2003
526
0.040
Why?
Time Factors
3
2016
6077
0.030
Why?
Disease-Free Survival
2
2008
618
0.030
Why?
Risk Factors
4
2016
8614
0.030
Why?
Shock
1
2016
83
0.030
Why?
Follow-Up Studies
3
2008
4392
0.030
Why?
Erythrocyte Transfusion
1
2016
161
0.030
Why?
Cause of Death
1
2016
362
0.030
Why?
Health Care Rationing
2
2004
45
0.030
Why?
Hemoglobins
1
2016
308
0.030
Why?
Cyclosporine
2
2003
161
0.020
Why?
Neoplasm Staging
2
2007
1162
0.020
Why?
Cohort Studies
3
2008
4883
0.020
Why?
Patient Selection
2
2004
629
0.020
Why?
Liver
2
2007
1633
0.020
Why?
Adolescent
3
2016
17802
0.020
Why?
Tissue and Organ Harvesting
1
2008
62
0.020
Why?
Functional Laterality
1
2008
196
0.020
Why?
Tomography, X-Ray Computed
2
2006
2272
0.020
Why?
Portography
1
2006
11
0.020
Why?
Delayed-Action Preparations
1
2007
158
0.020
Why?
Ultrasonics
1
2006
46
0.020
Why?
Colorado
2
2008
4090
0.020
Why?
Biomarkers
1
2016
3397
0.020
Why?
Simplexvirus
1
2006
80
0.020
Why?
Neoplasm Invasiveness
1
2007
438
0.020
Why?
Blood Vessels
1
2007
179
0.020
Why?
Aged
3
2008
18971
0.020
Why?
Kaplan-Meier Estimate
1
2008
813
0.020
Why?
Elective Surgical Procedures
1
2006
150
0.020
Why?
Treatment Failure
1
2006
330
0.020
Why?
Safety
1
2007
298
0.020
Why?
Preoperative Care
1
2007
319
0.020
Why?
Waiting Lists
1
2006
206
0.010
Why?
Proportional Hazards Models
1
2008
1078
0.010
Why?
Diabetes Mellitus, Type 1
1
2000
3254
0.010
Why?
Survival
1
2004
37
0.010
Why?
alpha-Fetoproteins
1
2004
31
0.010
Why?
Transplants
1
2004
36
0.010
Why?
Microsomes, Liver
1
2003
54
0.010
Why?
Outpatients
1
2006
325
0.010
Why?
Muromonab-CD3
1
2003
20
0.010
Why?
Ultrasonography
1
2006
635
0.010
Why?
Postoperative Complications
2
2004
2122
0.010
Why?
Cost Control
1
2003
39
0.010
Why?
Alkaline Phosphatase
1
2003
142
0.010
Why?
Cost Savings
1
2003
74
0.010
Why?
Hospitals, University
1
2003
169
0.010
Why?
Child
2
2016
18404
0.010
Why?
Neoplasm Recurrence, Local
1
2007
850
0.010
Why?
Aspartate Aminotransferases
1
2002
85
0.010
Why?
Alanine Transaminase
1
2002
141
0.010
Why?
Incidence
1
2007
2314
0.010
Why?
Young Adult
1
2016
10446
0.010
Why?
Multivariate Analysis
1
2003
1422
0.010
Why?
Risk Assessment
1
2008
2958
0.010
Why?
Predictive Value of Tests
1
2003
1791
0.010
Why?
Anastomosis, Surgical
1
1998
135
0.010
Why?
Liver Failure, Acute
1
1998
58
0.010
Why?
Dose-Response Relationship, Drug
1
2002
1836
0.010
Why?
Age Factors
1
2004
2885
0.010
Why?
Prevalence
1
2003
2247
0.010
Why?
Models, Biological
1
2003
1611
0.010
Why?
Severity of Illness Index
1
2003
2537
0.010
Why?
Magnetic Resonance Imaging
1
2006
3039
0.010
Why?
Diabetes Mellitus
1
2003
898
0.010
Why?
Obesity
1
2003
2505
0.010
Why?
Child, Preschool
1
2004
9115
0.010
Why?
Bak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)